Perrigo Company

PRGONYSEUSD

THESIS ALERT

Email me when the PRGO thesis changes

Evidence-based analysis, not personalized investment advice. Every alert email carries an unsubscribe link.

Follow on X
$16.55
−$0.28 (−1.66%)Today 1M +11.75%
After hours$16.57+0.11%

Updated Nov 11, 4:00 PM ET · Regular session · May be delayed

Source valuation snapshot. Not a live recalculation.
Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
Diluted earnings per share from the latest filed annual.
$16.83
Prior regular-session close from the quote source.
$16.38–$16.72
Regular-session low and high so far today.
1.3M
Regular-session shares traded · Nov 11, 4:00 PM ET.
Not yet confirmed
The company has not confirmed its next report date. Reported quarters are available in the chart’s Earnings view.
$9.23–$17.02
52-week trading low and high returned by the quote source.

Understand the Business

Why the Stock Moved

Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.

The core investment thesis

Own PRGO if underlying operations and margins recover, the company’s steady revenue and positive operating cash flow should justify a re-rate and equity upside.

PRGO price history

Latest price$16.55Today−$0.28 (-1.66%)
PRGO +7.47%S&P 500 -2.42%Since first plotted close
4 hours

Loading recent earnings…

Investment thesis

What must happen next

4 MATERIAL PROPOSITIONS
  • Despite the FY2025 GAAP operating loss, Perrigo’s core operations continue to produce positive operating cash flow, so management has runway to restore operating profitability and service leverage without immediate equity dilution.StrengtheningMateriality: High

    NetCashProvidedByUsedInOperatingActivities (operating_cash_flow) remained positive at $238,500,000 in FY2025. If true, investors can expect recovery via cost actions and non-cash charge normalization; if false (OCF falls), the company may need asset sales, debt restructuring, or dilutive financing.

    Watch: Loss of a major retail/manufacturing contract to a competitor or a decision by a large private-label customer to insource production.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    NetCashProvidedByUsedInOperatingActivities (operating_cash_flow) remained positive at $238,500,000 in FY2025.

    Open source ↗
  • Perrigo’s gross-profit base has been relatively stable across 2023–2025, implying manufacturing scale and pricing relationships that can protect gross margins and allow recovery of reported operating losses through cost and SG&A actions.HoldingMateriality: High

    GrossProfit was $1,680,400,000 in FY2023, $1,542,700,000 in FY2024, and $1,494,500,000 in FY2025 — a modest decline versus the operating income swing. If gross margins hold, operating leverage and cost reductions can restore operating income; if gross_profit erodes, there is limited room to recover margins and cash flow.

    Watch: A large customer shifts volumes to lower-cost offshore manufacturers, removing scale benefits.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GrossProfit was $1,680,400,000 in FY2023, $1,542,700,000 in FY2024, and $1,494,500,000 in FY2025 — a modest decline versus the operating income.

    Open source ↗
  • Perrigo’s positive operating cash flow and cash balance should be sufficient to service near-term liabilities and debt, provided operating_cash_flow does not materially decline.HoldingMateriality: Medium

    Total liabilities were $5,599,700,000 as of FY2025 while operating_cash_flow was positive in FY2025 ($238,500,000). If the balance sheet remains serviceable, the company can avoid distress actions and execute restructuring to restore operating income; if not, it risks forced asset sales or dilution.

    Watch: Upcoming large debt maturities or covenant tests that require refinancing in a higher-rate environment.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Total liabilities were $5,599,700,000 as of FY2025 while operating_cash_flow was positive in FY2025 ($238,500,000).

    Open source ↗
  • The FY2025 operating loss largely reflects non-recurring impairments or charges (not ongoing operating weakness); therefore GAAP earnings understate the company’s recoverable operating economics.HoldingMateriality: Medium

    OperatingIncomeLoss swung from positive ($151,900,000 in FY2023. If the loss is one-time, restoring operating income is a matter of time and execution; if the charges are recurring or reflect structural losses, the stock may need to be permanently re-rated lower.

    Watch: MD&A or notes revealing that the charges are the first of recurring reserve/impairment events tied to declining product demand.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    OperatingIncomeLoss swung from positive ($151,900,000 in FY2023.

    Open source ↗
Full investment case & evidence

Loading the original research archive…

Original research

Despite the FY2025 GAAP operating loss, Perrigo’s core operations continue to produce positive operating cash flow, so management has runway to restore operating profitability and service leverage without immediate equity dilution. If true, investors can expect recovery via cost actions and non-cash charge normalization; if false (OCF falls), the company may need asset sales, debt restructuring, or dilutive financing.

Perrigo’s gross-profit base has been relatively stable across 2023–2025, implying manufacturing scale and pricing relationships that can protect gross margins and allow recovery of reported operating losses through cost and SG&A actions. If gross margins hold, operating leverage and cost reductions can restore operating income; if gross_profit erodes, there is limited room to recover margins and cash flow.

Perrigo’s positive operating cash flow and cash balance should be sufficient to service near-term liabilities and debt, provided operating_cash_flow does not materially decline. If the balance sheet remains serviceable, the company can avoid distress actions and execute restructuring to restore operating income; if not, it risks forced asset sales or dilution.

The FY2025 operating loss largely reflects non-recurring impairments or charges (not ongoing operating weakness); therefore GAAP earnings understate the company’s recoverable operating economics. If the loss is one-time, restoring operating income is a matter of time and execution; if the charges are recurring or reflect structural losses, the stock may need to be permanently re-rated lower.

All standing thesis claims
Original report summary

underlying operations and margins recover, the company’s steady revenue and positive operating cash flow should justify a re-rate and equity upside.

Evidence assessed Nov 7, 2026. Expand each conclusion for its evidence and what would change it. Thesis evidence—not a buy or sell recommendation.

Bull case and bear case

Bull case and bear case for PERRIGO Co

Where the evidence on PERRIGO Co stands: Holding on the latest evidence (Nov 7, 2026). Of its 4 thesis points, 1 strengthening and 3 holding.

Bull case: what the evidence supports

  • Despite the FY2025 GAAP operating loss, Perrigo’s core operations continue to produce positive operating cash flow, so management has runway to restore operating profitability and service leverage without immediate equity dilution.

    sec.gov ↗

  • Perrigo’s gross-profit base has been relatively stable across 2023–2025, implying manufacturing scale and pricing relationships that can protect gross margins and allow recovery of reported operating losses through cost and SG&A actions.

    sec.gov ↗

  • Perrigo’s positive operating cash flow and cash balance should be sufficient to service near-term liabilities and debt, provided operating_cash_flow does not materially decline.

    sec.gov ↗

  • The FY2025 operating loss largely reflects non-recurring impairments or charges (not ongoing operating weakness); therefore GAAP earnings understate the company’s recoverable operating economics.

    sec.gov ↗

Bear case: what would count against it

  • Loss of a major retail/manufacturing contract to a competitor or a decision by a large private-label customer to insource production.

    sec.gov ↗

  • A large customer shifts volumes to lower-cost offshore manufacturers, removing scale benefits.

    sec.gov ↗

  • Upcoming large debt maturities or covenant tests that require refinancing in a higher-rate environment.

    sec.gov ↗

Thesis-Break Engine

Thesis-break watch · PERRIGO Co

Loading the break-condition record for PERRIGO Co.

How the Thesis-Break Engine works →Historical outcomes are measured against the market after past breaks of the same kind, across all companies. Not a prediction.

MARKET + FINANCIAL SNAPSHOT

The numbers behind the thesis

Sourced from filings and market data

What Changed

  1. Mixed
    Reported results of operations (earnings release).

    PERRIGO Co filed an SEC 8-K on 2026-11-04: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

  2. Mixed
    Regulation FD disclosure.

    PERRIGO Co filed an SEC 8-K on 2026-10-29: Regulation FD disclosure. It is a dated development that tests the current thesis.

  3. Mixed
    Reported results of operations (earnings release).

    PERRIGO Co filed an SEC 8-K on 2026-08-05: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

Risks / falsifiers

What could break the thesis

  • Loss of a major retail/manufacturing contract to a competitor or a decision by a large private-label customer to insource production.
  • A large customer shifts volumes to lower-cost offshore manufacturers, removing scale benefits.
  • Upcoming large debt maturities or covenant tests that require refinancing in a higher-rate environment.
  • MD&A or notes revealing that the charges are the first of recurring reserve/impairment events tied to declining product demand.

PRGO news

Loading headlines…

Financial statements

PRGO income statement

Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.

PRGO: quick answers

Have members of Congress traded PRGO?
Reports made public in the last 90 days disclose 2 trades in PRGO by 1 filer: 1 purchase and 1 sale. They are filed under the STOCK Act by members of Congress, the President and senior officials. Every disclosed PRGO trade
Which well-known investors own PRGO?
2 of the 37 well-known funds tracked here reported PRGO shares in their latest 13F filings. By share of the fund's portfolio: Maverick Capital, 0.0%; Bridgewater Associates (Ray Dalio), 0.0%. Fund portfolios

PRGO in well-known investors’ portfolios

2 of 37 funds reported PRGO shares in their latest 13F filing. A 13F shows quarter-end positions and arrives up to 45 days later.

FundOf its portfolioValueChangeQuarter
Maverick Capital0.04%$4.7MNewQ2 2026
Ray DalioBridgewater Associates0.01%$3.4M+158.5%Q2 2026

Every fund’s portfolio

ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.